N29H (p.Asn29His) variant of TP53 (Cellular tumor antigen p53)
N29H (p.Asn29His) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes experimental measurements and structural context.
N29H (p.Asn29His) variant details
- p.Asn29His
- Ensembl rs1597375899
- Likely benign
- Missense
- Variant Prioritization Score for Impact Estimate 0.267
- ESM-1b 0.00
- AlphaMissense 0.10
- EBI: Likely benign
- UniProt: Likely benign
- Structural context available
- p53 variant effect measured by cell growth: score -0.641